新型合成阿片cyclopropylfentanyl与其他新型合成阿片在呼吸功能不全昏迷患者中的毒理学分析检出
本文报告2017年某大学医学中心急诊科收治的三例严重中毒病例,均为观察性病例系列。患者及家属均否认用药,但临床表现为意识丧失、呼吸减慢、高碳酸血症、动脉低血压和瞳孔缩小等严重阿片中毒征象。采用GC-MS、LC-QTOF-MS和LC-MS-MS对血清、尿液及一例病房内粉末样本进行毒理学分析,所有病例体液均检出环丙基芬太尼,两例还检出其他合成阿片及帽柱木碱或desoxypipradrol。两例血清环丙基芬太尼浓度分别为51和76 ng/ml。作者认为,无病史的中毒病例需详细毒理学分析以发现标准筛查未覆盖的新型精神活性物质。
要点
- 三例患者均否认用药,但均出现意识丧失、呼吸减慢、高碳酸血症、动脉低血压和瞳孔缩小等严重阿片中毒表现。
- 所有病例体液均检出环丙基芬太尼,两例血清浓度分别为51 ng/ml和76 ng/ml。
- 两例同时检出其他合成阿片(U-47700、甲氧基乙酰芬太尼、丁酰芬太尼、2-氟异丁酰芬太尼或4-氟异丁酰芬太尼)及帽柱木碱或desoxypipradrol。
- 一例病房内粉末样本含环丙基芬太尼、环丙基去甲芬太尼、乙酰芬太尼、4-ANPP、U-47700和咖啡因,除乙酰芬太尼外均在各对应血、尿样本中检出。
- 作者认为,无病史的中毒病例详细毒理学分析可揭示标准毒理学筛查未覆盖的新型精神活性物质。
适用人群与场景
- 2017年某大学医学中心急诊科收治的三例严重中毒患者,患者及家属均否认用药。
红旗征与不能漏的情况
- 严重阿片中毒表现:意识丧失、呼吸减慢、高碳酸血症、动脉低血压和瞳孔缩小,可能危及生命。
研究设计与关键结果
- 观察性病例系列,纳入2017年某大学医学中心急诊科收治的三例中毒患者。
- 采用GC-MS、LC-QTOF-MS和LC-MS-MS对血清、尿液及一例病房内粉末样本进行毒理学分析。
- 所有病例体液均检出环丙基芬太尼;两例还检出U-47700、甲氧基乙酰芬太尼、丁酰芬太尼、2-氟异丁酰芬太尼或4-氟异丁酰芬太尼,以及帽柱木碱或desoxypipradrol。
- 一例粉末样本含环丙基芬太尼、环丙基去甲芬太尼、乙酰芬太尼、4-ANPP、U-47700和咖啡因,除乙酰芬太尼外均在各对应血、尿样本中检出。
- 两例血清环丙基芬太尼浓度分别为51 ng/ml和76 ng/ml。
证据类型、等级与局限
- 证据类型:观察性病例系列(三例)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,中毒病例无病史时,详细毒理学分析可能揭示标准毒理学筛查未覆盖的新型精神活性物质。
- 作者认为,新型产品药理效力高且毒理学数据与协同效应未知,可能轻易导致危及生命的过量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: Fentanyl derivatives like cyclopropylfentanyl have recently appeared on the recreational drug market. Cyclopropylfentanyl is probably a highly potent opioid, but human toxicological data are not available so far. Similar to other fentanyl derivatives the most serious acute health risk due to the use of cyclopropylfentanyl is likely to be respiratory depression. In case of overdose, this may lead to apnoea, respiratory arrest and death. In this paper, we present three cases of severe intoxication with cyclopropylfentanyl. Methods: Observational case series including three intoxications treated in the Emergency Department at the University Medical Centre in 2017. In all cases, the consumption of any drugs was denied by the patients and relatives. Toxicological analyses using GC-MS, LC-QTOF-MS and LC-MS-MS of serum, urine samples and in one case of a powder sample, found in the hospital room, were performed. Medical records were reviewed to obtain clinical data. Results: Clinical effects of severe opioid intoxications comprising loss of consciousness, bradypnea, hypercapnia, arterial hypotension and miosis were recorded. In all cases, the novel fentanyl analogue cyclopropylfentanyl was detected in body fluids. In two cases further synthetic opioids (U-47700, methoxyacetylfentanyl, butyrfentanyl, 2-fluoroiso- or 4-fluoroisobutyrfentanyl) and mitragynine or desoxypipradrol were found. A discovered powder sample contained cyclopropylfentanyl, cyclopropylnorfentanyl, acetylfentanyl, 4-ANPP, U-47700 and caffeine. Except for acetylfentanyl all ingredients could be detected in the respective blood and urine sample. In two cases a cyclopropylfentanyl serum concentration of 51 and 76 ng/ml was determined. Discussion: In three cases of severe potentially life-threatening intoxication, cyclopropylfentanyl was verified using different analytical procedures. The ingested substance, as well as the excreted metabolites, were detected by application of various mass spectrometric techniques. Conclusions: In cases of intoxication without a medical history, the detailed toxicological analysis may reveal new psychoactive substances which are not detected by standard toxicological screening approaches. The high pharmacological potency of new products with unknown toxicological data and unknown synergistic effects may easily lead to a life-threatening overdose.
参考来源
- Müller D, Neurath H, Neukamm MA, et al. New synthetic opioid cyclopropylfentanyl together with other novel synthetic opioids in respiratory insufficient comatose patients detected by toxicological analysis. Clin Toxicol (Phila). 2019. PMID: 30775936. doi:10.1080/15563650.2018.1554187
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。